Alterome Therapeutics, Inc

United States - San Diego, California

• 09/04/2024
• Series B
• $132,000,000

Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with expertise in multiple areas of science and operations, dedicated to co-elevating toward our vision to bring life-changing and life-saving therapies to cancer patients. We believe in our journey, in each other, and in our ability to collaboratively develop therapies that will help end cancers. Thus, we seek the best people for our company and provide the resources they need to grow, develop, and accomplish our collective goals. We are moving forward with humility & empathy, fearlessness & resilience, with a sense of inclusion & belonging, open communication and a deep trust. And…we manage to have a lot of fun along the way!

Related People

Eric MurphyFounder

United States - San Diego Metropolitan Area

Life science entrepreneur that assembles high performing teams with a clear mission:
to create and deliver innovative medicines.

Experienced in cancer research, drug discovery, pharmacology, and drug development.

Unique leadership foundation established from positions in academia, biotech, large pharma, and CRO life science sectors.

Fueled by a passion to inspire hope for cancer patients. #Onward

LinkedIn https://www.linkedin.com/in/murphness/